Thomas, R., Sanders, S., Doust, J., Beller, E. & Glasziou, P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 135, e994–e1001 (2015).
Fayyad, J. et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br. J. Psychiatry 190, 402–409 (2007).
Faraone, S., Biederman, J. & Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta analysis of follow-up studies. Psychol. Med. 36, 159–165 (2006).
Burt, S. Rethinking environmental contributions to child and adolescent psychopathology: a meta-analysis of shared environmental influences. Psychol. Bull. 135, 608–637 (2009).
Chang, Z., Lichtenstein, P., Asherson, P. & Larsson, H. Developmental twin study of attention problems: high heritabilities throughout development. JAMA Psychiatry 70, 311–318 (2013).
Pingault, J.-B. et al. Genetic and environmental influences on the developmental course of attention-deficit/hyperactivity disorder symptoms from childhood to adolescence. JAMA Psychiatry 72, 651–658 (2019).
Cloninger, C., Svrakic, D. & Przybeck, T. A psychobiological model of temperament and character. Arch. Gen. Psychiatry 50, 975–990 (1993).
Downey, K., Stelson, F., Pomerleau, O. & Giordani, B. Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population. J. Nerv. Ment. Dis. 185, 32–38 (1997).
Lynn, D. et al. Temperament and character profiles and the dopamine D4 receptor gene in ADHD. Am. J. Psychiatry 162, 906–914. (2005).
Anckarsäter, H. et al. The impact of ADHD and autism spectrum disorders on temperament, character, and personality development. Am. J. Psychiatry 163, 1239–1244 (2006).
Jacob, C. et al. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur. Arch. Psychiatry Clin. Neurosci. 257, 309–317 (2007).
Faraone, S., Kunwar, A., Adamson, J. & Biederman, J. Personality traits among ADHD adults: implications of late onset and subthreshold diagnoses. Psychol. Med. 39, 685–693 (2009).
Salgado, C. et al. Inattention and hyperactivity dimensions of ADHD are associated with different personality profiles. Psychopathology 42, 108–112 (2009).
Smalley, S. et al. Mindfulness and attention deficit hyperactivity disorder. J. Clin. Psychol. 65, 1087–1098 (2009).
Merwood, A., Asherson, P. & Larsson, H. Genetic associations between the ADHD symptom dimensions and Cloninger’s temperament dimensions in adult twins. Eur. Neuropsychopharmacol. 23, 416–425 (2013).
Piazza, P. et al. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567, 169–174 (1991).
Hooks, M., Colvin, A., Juncos, J. & Justice, J. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res. 587, 306–312 (1992).
Lisman, J. & Grace, A. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46, 703–713 (2005).
Krebs, R., Heipertz, D., Schuetze, H. & Duzel, E. Novelty increases the mesolimbic functional connectivity of the substantia nigra/ventral tegmental area (SN/VTA) during reward anticipation: evidence from high-resolution fMRI. Neuroimage 58, 647–655 (2011).
Linder, M. & Deschenes, R. Palmitoylation: policing protein stability and traffic. Nat. Rev. Mol. Cell Biol. 8, 74–84 (2007).
Gao, X. & Hannoush, R. A decade of click chemistry in protein palmitoylation: impact on discovery and new biology. Cell Chem. Biol. 25, 236–246 (2018).
Tabaczar, S., Czogalla, A., Podkalicka, J., Biernatowska, A. & Sikorski, A. Protein palmitoylation: palmitoyltransferases and their specificity. Exp. Biol. Med. 242, 1150–1157 (2017).
Hornemann, T. Palmitoylation and depalmitoylation defects. J. Inherit. Metab. Dis. 38, 179–186 (2014).
Mukai, J. et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 36, 725–731 (2004).
Shen, L. et al. Role of S-palmitoylation by ZDHHC13 in mitochondrial function and metabolism in liver. Sci. Rep. 7, 2182 (2017).
Zhou, T. et al. Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy. Proc. Natl Acad. Sci. USA 112, 15666–15671 (2015).
Beard, R. et al. Palmitoyl acyltransferase DHHC21 mediates endothelial dysfunction in systemic inflammatory response syndrome. Nat. Commun. 7, 12823 (2016).
Raymond, F. et al. Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a marfanoid habitus. Am. J. Hum. Genet. 80, 982–987 (2007).
Sanders, S. et al. Curation of the mammalian palmitoylome indicates a pivotal role for palmitoylation in diseases and disorders of the nervous system and cancers. PLoS Comput. Biol. 11, e1004405 (2015).
Fukata, Y. & Fukata, M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat. Rev. Neurosci. 11, 161–175 (2010).
Huang, K. & El-Husseini, A. Modulation of neuronal protein trafficking and function by palmitoylation. Curr. Opin. Neurobiol. 15, 527–525. (2005).
Globa, A. & Bamji, S. Protein palmitoylation in the development and plasticity of neuronal connections. Curr. Opin. Neurobiol. 45, 210–220 (2017).
Holland, S. & Thomas, G. Roles of palmitoylation in axon growth, degeneration and regeneration. J. Neurosci. Res. 95, 1528–1539 (2017).
Bolland, D., Moritz, A., Stanislowski, D., Vaughan, R. & Foster, J. Palmitoylation by multiple DHHC enzymes enhances dopamine transporter function and stability. ACS Chem. Neurosci. 10, 2707–2717 (2019).
Foster, J. & Vaughan, R. Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase c-dependent regulation. J. Biol. Chem. 286, 5175–5186 (2011).
Rastedt, D., Vaughan, R. & Foster, J. Palmitoylation mechanisms in dopamine transporter regulation. J. Chem. Neuroanat. 83, 3–9 (2017).
Kong, M., Verma, V., O’Dowd, B. & George, S. The role of palmitoylation in directing dopamine D1 receptor internalization through selective endocytic routes. Biochem. Biophys. Res. Commun. 405, 445–449 (2011).
Zhang, X. et al. Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors. Biochim. Biophys. Acta 1858, 2152–2162 (2016).
Zhang, X. & Kim, K. Palmitoylation of the carboxyl-terminal tail of dopamine D4 receptor is required for surface expression, endocytosis, and signaling. Biochem. Biophys. Res. Commun. 479, 398–403 (2016).
Linder, M. et al. Lipid modifications of G proteins: α Subunits are palmitoylated. Proc. Natl Acad. Sci. USA 90, 3675–3679 (2002).
Ponimaskin, E. et al. The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity. J. Biol. Chem. 277, 2534–2546 (2002).
Klein, M. et al. Dopamine: functions, signaling, and association with neurological diseases. Cell Mol. Neurobiol. 39, 31–59 (2019).
Grace, A. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat. Rev. Neurosci. 17, 524–532 (2016).
Wang, F. et al. Zdhhc15b regulates differentiation of diencephalic dopaminergic neurons in zebrafish. J. Cell Biochem. 116, 2980–2991 (2015).
Shah, B., Shimell, J. & Bamji, S. Regulation of dendrite morphology and excitatory synapse formation by zDHHC15. J. Cell Sci. 132, jcs230052 (2019).
Fukata, M., Fukata, Y., Adesnik, H., Nicoll, R. & Bredt, D. Identification of PSD95 palmitoylating enzymes. Neuron 44, 987–996 (2004).
Greaves, J. & Chamberlain, L. DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem. Sci. 36, 245–253 (2011).
Mansouri, M. et al. Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation. Eur. J. Hum. Genet. 13, 970–977 (2005).
Piton, A., Redin, C. & Mandel, J. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am. J. Hum. Genet. 93, 368–383 (2013).
Moysés-Oliveira, M. et al. X-linked intellectual disability related genes disrupted by balanced X-autosome translocations. Am. J. Med. Genet. 168, 669–677 (2015).
West, M. New stereological methods for counting neurons. Neurobiol. Aging 14, 275–285 (1993).
Tandrup, T., Gundersen, H. & Jensen, E. The optical rotator. J. Microsc. 186, 108–120 (1997).
Wan, J., Roth, A., O’Bailey, A. & Davis, N. Palmitoylated proteins: purification and identification. Nat. Protoc. 2, 1573–1584 (2007).
Krasnova, I. et al. Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex. Neurotox. Res. 11, 107–130 (2007).
Niwa, M. et al. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339, 335–339 (2013).
Giros, B., Jaber, M., Jones, S., Wightman, R. & Caron, M. hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606–612 (1996).
Leo, D. et al. Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats. J. Neurosci. 38, 1959–1972 (2018).
Faraone, S. The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci. Biobehav. Rev. 87, 255–270 (2018).
Pogorelov, V., Rodriguiz, R., Insco, M., Caron, M. & Wetsel, W. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 30, 1818–1831 (2005).
Ford, C. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282, 13–22 (2014).
Tsutsumi, R., Fukata, Y. & Fukata, M. Discovery of protein-palmitoylating enzymes. Pflug. Arch. 456, 1199–1206 (2008).
Wood, A., Rijsdijk, F., Asherson, P. & Kuntsi, J. Inferring causation from cross-sectional data: examination of the causal relationship between hyperactivity-impulsivity and novelty seeking. Front Genet. 2, 6 (2011).
Ljungberg, T., Apicella, P. & Schultz, W. Responses of monkey dopamine neurons during learning of behavioral reactions. J. Neurophysiol. 67, 145–163 (1992).
Horvitz, J., Stewart, T. & Jacobs, B. Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat. Brain Res. 759, 251–258 (1997).
Ebstein, R. et al. Dopamine D4 receptor (DRD4) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet. 12, 78–80 (1996).
Ebstein, R. Saga of an adventure gene: novelty seeking, substance abuse and the dopamine D4 receptor exon III repeat polymorphism. Mol. Psychiatry 2, 381–384 (1997).
Lusher, J. & Ball, D. Dopamine D4 receptor gene (DRD4) is associated with Novelty Seeking (NS) and substance abuse: the saga continues. Mol. Psychiatry 6, 497–499 (2001).